This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n5http://localhost/temp/predkladatel/
n11http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n14http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n13http://reference.data.gov.uk/id/gregorian-year/
n7http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61988987%3A17110%2F14%3AA1501A5P%21RIV15-MSM-17110___/

Statements

Subject Item
n2:RIV%2F61988987%3A17110%2F14%3AA1501A5P%21RIV15-MSM-17110___
rdf:type
skos:Concept n14:Vysledek
dcterms:description
Introduction: Obesity is associated with a number health-related problems as well as a shortened life span, treating obesity is an important clinical concern. In this study, we examined the effects of the intragastric balloon MedSil? on anthropometric measures and hormones associated with lipid and energy metabolism Methods: Twenty-two obese patients underwent insertion of the intragastric balloon MedSil? following a clinical exam, body composition scan and collection of blood samples. Results: Six months following insertion of the MedSil? balloon, we observed significant decreases in body weight, body mass index, and fat mass. Compared with baseline levels, ghrelin serum levels were increased significantly, while leptin, FGF21 and glycated hemoglobin levels significantly decreased, 6 months after balloon insertion. Conclusion: The MedSil? intragastric balloon is a safe and effective treatment for morbid obesity, with positive effects on anthropometric measures and lipid metabolism. Introduction: Obesity is associated with a number health-related problems as well as a shortened life span, treating obesity is an important clinical concern. In this study, we examined the effects of the intragastric balloon MedSil? on anthropometric measures and hormones associated with lipid and energy metabolism Methods: Twenty-two obese patients underwent insertion of the intragastric balloon MedSil? following a clinical exam, body composition scan and collection of blood samples. Results: Six months following insertion of the MedSil? balloon, we observed significant decreases in body weight, body mass index, and fat mass. Compared with baseline levels, ghrelin serum levels were increased significantly, while leptin, FGF21 and glycated hemoglobin levels significantly decreased, 6 months after balloon insertion. Conclusion: The MedSil? intragastric balloon is a safe and effective treatment for morbid obesity, with positive effects on anthropometric measures and lipid metabolism.
dcterms:title
Effects of the Intragastric Balloon MedSil (R) on Weight Loss, Fat Tissue, Lipid Metabolism, and Hormones Involved in Energy Balance Effects of the Intragastric Balloon MedSil (R) on Weight Loss, Fat Tissue, Lipid Metabolism, and Hormones Involved in Energy Balance
skos:prefLabel
Effects of the Intragastric Balloon MedSil (R) on Weight Loss, Fat Tissue, Lipid Metabolism, and Hormones Involved in Energy Balance Effects of the Intragastric Balloon MedSil (R) on Weight Loss, Fat Tissue, Lipid Metabolism, and Hormones Involved in Energy Balance
skos:notation
RIV/61988987:17110/14:A1501A5P!RIV15-MSM-17110___
n3:aktivita
n6:S
n3:aktivity
S
n3:cisloPeriodika
6
n3:dodaniDat
n13:2015
n3:domaciTvurceVysledku
n11:2211335 n11:8271267 n11:2106981 n11:3431746 n11:2058693 n11:2131390 n11:4299434
n3:druhVysledku
n16:J
n3:duvernostUdaju
n15:S
n3:entitaPredkladatele
n7:predkladatel
n3:idSjednocenehoVysledku
13787
n3:idVysledku
RIV/61988987:17110/14:A1501A5P
n3:jazykVysledku
n8:eng
n3:klicovaSlova
Intragastric balloon; Leptin; Ghrelin; FGF21; Lipid metabolism; Fat tissue; Weight loss
n3:klicoveSlovo
n4:Ghrelin n4:Weight%20loss n4:Fat%20tissue n4:FGF21 n4:Lipid%20metabolism n4:Intragastric%20balloon n4:Leptin
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[69E6285451E3]
n3:nazevZdroje
OBES SURG
n3:obor
n17:FB
n3:pocetDomacichTvurcuVysledku
7
n3:pocetTvurcuVysledku
7
n3:rokUplatneniVysledku
n13:2014
n3:svazekPeriodika
24
n3:tvurceVysledku
Machytka, Evžen Zonča, Pavel Švagera, Zdeněk Kupka, Tomáš Zavadilová, Vladislava Klvaňa, Pavel Bužga, Marek
n3:wos
000336372300013
s:issn
0960-8923
s:numberOfPages
7
n5:organizacniJednotka
17110